背景:考虑到当前有效治疗方法的数量有限,多药耐药(MDR)疾病已成为公共卫生的严重问题。由于对多种抗生素的耐药性的出现,寻找新的抗菌药物已成为必要。类黄酮的使用是一种植物治疗策略,已被研究为该问题的潜在补救措施。已发现称为类黄酮的次要植物化合物对抗性微生物具有抗菌作用。
目的:这篇综述旨在让读者了解有关黄酮类化合物对抗MDR感染潜力的当代研究。
方法:对电子数据库进行了系统搜索(PubMed,Scopus,和谷歌学者)使用相关关键词,如类黄酮,MDR感染,抗菌活性,和抗性微生物。本综述包括研究黄酮类化合物对抗性微生物的抗菌活性的研究。
结果:大多数研究发现,黄酮类化合物对抗性微生物具有抗菌作用,一些还表明它们与传统抗生素有协同作用。黄酮类槲皮素,山奈酚,芹菜素,木犀草素是最经常被研究的。根据研究,类黄酮影响微生物基因表达,抑制微生物酶,破坏微生物细胞膜的完整性.此外,一些研究已经注意到类黄酮的低毒性和安全性。
结论:对于治疗对许多药物耐药的感染,类黄酮构成一类有前途的植物治疗剂。开发基于类黄酮的治疗方法,用于治疗MDR疾病,并评估类黄酮作为常规抗菌药物佐剂的潜力,需要更多的研究。
BACKGROUND: Considering the limited number of current effective treatments, Multidrug- Resistant (MDR) illnesses have grown to be a serious concern to public health. It has become necessary to look for new antimicrobial drugs because of the emergence of resistance to numerous kinds of antibiotics. The use of flavonoids is one phytotherapeutic strategy that has been researched as a potential remedy for this issue. Secondary plant compounds called flavonoids have been found to have an antibacterial effect against resistant microorganisms.
OBJECTIVE: This review seeks to give readers a glimpse into contemporary studies on flavonoids\' potential to fight MDR infections.
METHODS: A systematic search was conducted on electronic databases (PubMed, Scopus, and Google Scholar) using relevant keywords such as flavonoids, MDR infections, antimicrobial activity, and resistance microbes. Studies that investigated the antimicrobial activity of flavonoids against resistant microbes were included in this review.
RESULTS: Most research found that flavonoids have antibacterial efficacy against resistant microorganisms, and some also showed that they have synergistic benefits with traditional antibiotics. The flavonoids quercetin, kaempferol, apigenin, and luteolin were the most often investigated ones. According to research, flavonoids affect microbial gene expression, inhibit microbial enzymes, and disrupt the integrity of microbial cell membranes. Additionally, a few studies have noted the flavonoids\' low toxicity and safety.
CONCLUSIONS: For the treatment of infections that are resistant to many drugs, flavonoids constitute a promising class of phytotherapeutic agents. To develop flavonoid-based treatment methods for treating MDR illnesses and assess the potential of flavonoids as adjuvants to conventional antimicrobial drugs, more study is required.